G
Genetic Archaeology
GENETIC ARCHAEOLOGY // PROFILE

F2

Coagulation Factor II (Prothrombin / Thrombin)

CHR 11
11p11.2

Overview

The F2 gene provides the genetic template for prothrombin (coagulation factor II), the hepatic zymogen converted into active thrombin whenever blood must clot to seal a vessel injury.

In European populations, the gain-of-function Prothrombin G20210A variant (rs1799963) is the second most common inherited thrombophilia marker right after Factor V Leiden (F5)—detailed further in our thrombophilia genetics guide.

📍 Position
11p11.2 (Chromosome 11)
🏷️ Category
Hereditary Diseases & Coagulation
🧪 Function
Prothrombin Clotting Precursor
📊 Influence
Venous thrombosis predisposition

Function of F2 (Prothrombin)

Unlike coding defects that break a protein, the G20210A substitution sits in the 3′ untranslated regulatory tail of F2 mRNA, stabilizing transcripts so the liver exports ~25–30% more functional prothrombin into circulating plasma.

Key Aspects:

🩸 Clot Amplification Risk

Heterozygous A/G carriers face roughly a 2- to 3-fold higher lifetime odds of deep vein thrombosis (DVT) or pulmonary embolism—most carriers never clot unless a secondary trigger hits.

🧬 Synergy With Factor V Leiden

Double heterozygosity for F2 G20210A plus Factor V Leiden raises thromboembolic odds substantially (10–20x), guiding individualized surgery and obstetric prophylaxis.

💡 Clinical Triggers Matter Most: Combined estrogen contraception, surgery, immobilization, or postpartum recovery multiply risk far more than genetics alone—allowing targeted preventive steps.

🧬 Genetic Variants (SNPs)

Two variants on chromosome 11p11.2 characterize inherited prothrombin regulation:

rs1799963
11:46761055
Normal

G
/
Risk (20210A)

A
Prothrombin G20210A
Boosts mRNA polyadenylation efficiency and circulating prothrombin concentration, raising venous clot tendency 2–3x (heterozygotes).
20210A allele:
~2-3% (Europe)
rs3136516
11:46760422
Reference

A
/
Variant

G
F2 Intron 13 (19911A>G)
Common modifier weakly influencing clotting factor II expression when paired with other prothrombotic states.
G allele frequency:
~45% (Europe)

Practical Significance

✅ Strategies & Guidance

  • Hormonal Contraception Choice: Discuss progestin-only or non-hormonal options with your clinician before starting estrogen-containing pills.
  • Long-Haul Travel Habits: Walk hourly, hydrate well, flex calf muscles, and wear graduated compression stockings on flights >4–5 hours.
  • Surgical & Obstetric Alerts: Inform surgeons and OB/GYN teams prior to immobilization, orthopedic operations, or delivery.

⚠️ Clinical Notes & Risks

  • Deep Vein Thrombosis & PE: Unexplained unilateral leg swelling, warmth, or sudden shortness of breath requires urgent medical evaluation.
  • Postpartum Window: The 6 weeks following childbirth carry peak hypercoagulability, sometimes warranting temporary LMWH prophylaxis.
  • MTHFR Confusion: Unlike F2 G20210A, common MTHFR variants do not independently drive venous thrombosis.
🩺 Medical Disclaimer: Genetic test results for F2 (Coagulation Factor II (Prothrombin)) should always be interpreted alongside laboratory biomarkers, medications, and qualified medical or genetic counseling.

📚 Data Sources

  • OMIM: #176930 (Coagulation Factor II / Prothrombin)
  • dbSNP: rs1799963 (G20210A), rs3136516
  • ASH / ISTH Guidelines: Hereditary Thrombophilia Testing & Management
  • ClinVar: rs1799963 Pathogenic Risk Factor Annotation

Last Update: November 2026

Related Research Guides for F2

Related Genes in Hereditary Diseases